Cargando…

Plasma Glutamine Concentrations in Liver Failure

BACKGROUND: Higher than normal plasma glutamine concentration at admission to an intensive care unit is associated with an unfavorable outcome. Very high plasma glutamine levels are sometimes seen in both acute and chronic liver failure. We aimed to systematically explore the relation between differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Helling, Gunnel, Wahlin, Staffan, Smedberg, Marie, Pettersson, Linn, Tjäder, Inga, Norberg, Åke, Rooyackers, Olav, Wernerman, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777432/
https://www.ncbi.nlm.nih.gov/pubmed/26938452
http://dx.doi.org/10.1371/journal.pone.0150440
_version_ 1782419297014906880
author Helling, Gunnel
Wahlin, Staffan
Smedberg, Marie
Pettersson, Linn
Tjäder, Inga
Norberg, Åke
Rooyackers, Olav
Wernerman, Jan
author_facet Helling, Gunnel
Wahlin, Staffan
Smedberg, Marie
Pettersson, Linn
Tjäder, Inga
Norberg, Åke
Rooyackers, Olav
Wernerman, Jan
author_sort Helling, Gunnel
collection PubMed
description BACKGROUND: Higher than normal plasma glutamine concentration at admission to an intensive care unit is associated with an unfavorable outcome. Very high plasma glutamine levels are sometimes seen in both acute and chronic liver failure. We aimed to systematically explore the relation between different types of liver failure and plasma glutamine concentrations. METHODS: Four different groups of patients were studies; chronic liver failure (n = 40), acute on chronic liver failure (n = 20), acute fulminant liver failure (n = 20), and post-hepatectomy liver failure (n = 20). Child-Pugh and Model for End-stage Liver Disease (MELD) scores were assessed as indices of liver function. All groups except the chronic liver failure group were followed longitudinally during hospitalisation. Outcomes were recorded up to 48 months after study inclusion. RESULTS: All groups had individuals with very high plasma glutamine concentrations. In the total group of patients (n = 100), severity of liver failure correlated significantly with plasma glutamine concentration, but the correlation was not strong. CONCLUSION: Liver failure, regardless of severity and course of illness, may be associated with a high plasma glutamine concentration. Further studies are needed to understand whether high glutamine levels should be regarded as a biomarker or as a contributor to symptomatology in liver failure.
format Online
Article
Text
id pubmed-4777432
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47774322016-03-10 Plasma Glutamine Concentrations in Liver Failure Helling, Gunnel Wahlin, Staffan Smedberg, Marie Pettersson, Linn Tjäder, Inga Norberg, Åke Rooyackers, Olav Wernerman, Jan PLoS One Research Article BACKGROUND: Higher than normal plasma glutamine concentration at admission to an intensive care unit is associated with an unfavorable outcome. Very high plasma glutamine levels are sometimes seen in both acute and chronic liver failure. We aimed to systematically explore the relation between different types of liver failure and plasma glutamine concentrations. METHODS: Four different groups of patients were studies; chronic liver failure (n = 40), acute on chronic liver failure (n = 20), acute fulminant liver failure (n = 20), and post-hepatectomy liver failure (n = 20). Child-Pugh and Model for End-stage Liver Disease (MELD) scores were assessed as indices of liver function. All groups except the chronic liver failure group were followed longitudinally during hospitalisation. Outcomes were recorded up to 48 months after study inclusion. RESULTS: All groups had individuals with very high plasma glutamine concentrations. In the total group of patients (n = 100), severity of liver failure correlated significantly with plasma glutamine concentration, but the correlation was not strong. CONCLUSION: Liver failure, regardless of severity and course of illness, may be associated with a high plasma glutamine concentration. Further studies are needed to understand whether high glutamine levels should be regarded as a biomarker or as a contributor to symptomatology in liver failure. Public Library of Science 2016-03-03 /pmc/articles/PMC4777432/ /pubmed/26938452 http://dx.doi.org/10.1371/journal.pone.0150440 Text en © 2016 Helling et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Helling, Gunnel
Wahlin, Staffan
Smedberg, Marie
Pettersson, Linn
Tjäder, Inga
Norberg, Åke
Rooyackers, Olav
Wernerman, Jan
Plasma Glutamine Concentrations in Liver Failure
title Plasma Glutamine Concentrations in Liver Failure
title_full Plasma Glutamine Concentrations in Liver Failure
title_fullStr Plasma Glutamine Concentrations in Liver Failure
title_full_unstemmed Plasma Glutamine Concentrations in Liver Failure
title_short Plasma Glutamine Concentrations in Liver Failure
title_sort plasma glutamine concentrations in liver failure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777432/
https://www.ncbi.nlm.nih.gov/pubmed/26938452
http://dx.doi.org/10.1371/journal.pone.0150440
work_keys_str_mv AT hellinggunnel plasmaglutamineconcentrationsinliverfailure
AT wahlinstaffan plasmaglutamineconcentrationsinliverfailure
AT smedbergmarie plasmaglutamineconcentrationsinliverfailure
AT petterssonlinn plasmaglutamineconcentrationsinliverfailure
AT tjaderinga plasmaglutamineconcentrationsinliverfailure
AT norbergake plasmaglutamineconcentrationsinliverfailure
AT rooyackersolav plasmaglutamineconcentrationsinliverfailure
AT wernermanjan plasmaglutamineconcentrationsinliverfailure